Global Cardiology Surgical & Interventional Cardiology Devices Market Insights, Opportunity Analysis, Market Shares and Forecast 2016 – 2022
The prevalence of heart diseases globally increases the demand for interventional cardiology surgeries. The cardiology surgeries are costly and have some risk factor attached - there is 3-5% probability of patient’s death. The global increase in life style oriented diseases has indirectly put pressure on the economies of the nation. The patient alone does not bear the cost of the treatment. The funding comes from the government health programs, reimbursement policies and health insurances to enable the patient for getting treatment.
US is the largest market for the Cardiovascular surgery devices with 46% of global share. Europe has captured 27% of market share in the cardiovascular surgery devices. APAC has largest growth in the market which mainly comes from the China and Japan.
Key companies profiled include
1. Abbott Cardiovascular
2. Boston Scientific Corp.
3. C.R. Bard, Inc.
4. Cook Medical
5. Medtronic. Inc
6. Toshiba Medical systems
7. Biosense Webster, Inc.
8. Edwards Lifescience Corp.
9. Lombard Medical,
10. Atricure Inc.,
11. Atrium Medical Corporation.,
12. Johnson And Johnson,
13. GE Healthcare (Interventional Imaging),
14. Philips Healthcare(Interventional Imaging),
15. Smiths Medical(Interventional Imaging),
16. St. Judes Medical,
17. Hansen Medical,
18. Berlin Heart,
19. Cambridge Heart
This Occams Research Report covers
1. Historical data
2. Revenue forecasts, growth rates and CAGR upto 2022
3. Industry Analysis
4. Competitive Analysis
5. Key geographic growth data
6. Deep profiles top competitive companies
US is the largest market for the Cardiovascular surgery devices with 46% of global share. Europe has captured 27% of market share in the cardiovascular surgery devices. APAC has largest growth in the market which mainly comes from the China and Japan.
Key companies profiled include
1. Abbott Cardiovascular
2. Boston Scientific Corp.
3. C.R. Bard, Inc.
4. Cook Medical
5. Medtronic. Inc
6. Toshiba Medical systems
7. Biosense Webster, Inc.
8. Edwards Lifescience Corp.
9. Lombard Medical,
10. Atricure Inc.,
11. Atrium Medical Corporation.,
12. Johnson And Johnson,
13. GE Healthcare (Interventional Imaging),
14. Philips Healthcare(Interventional Imaging),
15. Smiths Medical(Interventional Imaging),
16. St. Judes Medical,
17. Hansen Medical,
18. Berlin Heart,
19. Cambridge Heart
This Occams Research Report covers
1. Historical data
2. Revenue forecasts, growth rates and CAGR upto 2022
3. Industry Analysis
4. Competitive Analysis
5. Key geographic growth data
6. Deep profiles top competitive companies
CHAP 1.EXECUTIVE SUMMARY
CHAP 2.MARKET OVERVIEW
2.1.Market Estimation Methodology
2.2.Value Chain analysis
2.2.1.Suppliers
2.2.2.Manufacturers
2.2.3.Distributors & Retailers
2.2.4.End Users
2.3.Key Buying Criteria
2.3.1.Quality
2.3.2.Price
2.3.3.Availability
2.3.4.Success rate
2.4.Key Strategies
2.4.1.Innovation Is The Key Industry Strategy to Overcome Competition
2.5.Partnerships, acquisitions and mergers
2.6.Product Launch- a make or break marketing strategy
CHAP 3.MARKET DETERMINANTS
3.1.Drivers
3.1.1.Global increase in life style oriented diseases & fatalities
3.1.2.Medical Tourism
3.1.3.Medical Tourism Organizations
3.1.4.Global increase in healthcare spending
3.1.5.Increasing awareness of healthy lifestyle to drive the market
3.2.Restraints
3.2.1.High Cost of Surgeries
3.2.2.Stringent government policies affect Cardiology market growth
3.3.Opportunities
3.3.1.Research and development to explore healthcare robotics
3.3.2.Technological advancements in surgeries
3.3.3.US FDA approved medical devices
3.4.Challenges
3.4.1.High cost and Adoption issues of medical devices for hospitals and clinics
3.4.2.Reliability Issues
CHAP 4.MARKET SEGMENTATION
4.1.Cardiac rhythm management
4.1.1.Cardiac rhythm management devices
4.1.2.ICD: Cardioverter/defibrillators (ICD's)
4.1.3.Atrial Fibrillation
4.1.3.1.Treatment Options for Atrial Fibrillation
4.1.3.2.Cox-Maze Open Heart Procedure
4.1.3.3.Catheter-based Cardiac Ablation Procedure
4.2.Surgery
4.2.1.Coronary arteries bypass grafting (CABG)
4.2.2.Angioplasty
4.2.3.Transmyocardial Laser Revascularization (TMR)
4.2.4.Heart valve Repair/Replacement
4.2.5.Arrhythmia Treatment
4.2.6.Aneurysm Repair
4.2.7.Heart Transplant
4.2.7.1.Surgery to Place Ventricular Assist Devices or Total Artificial Hearts
4.2.8.Open Heart Surgery
4.2.9.Types of open heart surgery
4.2.10.Off Pump Heart surgery
4.2.11.Minimally invasive surgeries
4.3.Imaging Devices
4.3.1.Still Imaging
4.3.2.Real time imaging
4.3.3.Magnetic Resonance Angiogram (MRA)
4.3.4.Fluoroscopy
4.3.5.Echocardiography
4.4.Cardiac Catheterization
CHAP 5.GEOGRAPHICAL ANALYSIS
5.1.North America
5.1.1.United States (U.S.)
5.1.1.1.US FDA is vigilant over interventional cardiology device market
5.1.2.Canada
5.1.2.1.CVD and other heart diseases are the leading cause of mortality in Canada
5.1.2.2.Regulations in Canada
5.2.Europe
5.2.1.United Kingdom (UK)
5.2.2.France
5.2.3.Germany
5.2.4.Italy
5.2.5.Spain
5.3.Asia Pacific
5.3.1.India
5.3.2.China
5.3.2.1.Diseases prevalent in China
5.3.3.Japan
5.3.4.Korea
5.3.5.Taiwan
5.4.Rest of the World
5.4.1.Brazil
5.4.2.Mexico
5.4.3.South Africa
CHAP 6.CORPORATE PROFILE
6.1.Boston Scientific Corporation
6.1.1.Overview
6.1.2.Boston Scientific Corporation products portfolio in Cardiac
6.1.3.SCOT Analysis
6.2.C.R. Bard
6.2.1.Overview
6.2.2.Bard product portfolio in Cardiac
6.2.3.SCOT Analysis
6.3.Medtronic
6.3.1.Overview
6.3.2.Medtronic product portfolio in Cardiac
6.3.3.Strategic Moves
6.3.4.SCOT Analysis
6.4.Abbot Laboratories
6.4.1.Overview
6.4.2.Abbott laboratories portfolio in cardiac
6.4.3.SCOT Analysis
6.5.St. Jude Medical
6.5.1.Overview
6.5.2.St. Jude medical products portfolio in cardiac
6.5.3.SCOT Analysis
6.6.Cook Medical
6.6.1.Overview
6.6.2.Cook Medical products portfolio in cardiac:
6.6.3.Strategic moves
6.6.4.SCOT Analysis
6.7.Biosense Webster
6.7.1.Overview
6.7.2.Biosense Webster products portfolio in cardiac
6.7.3.SCOT Analysis
6.8.Edwards Lifescience
6.8.1.Overview
6.8.2.Edwards Lifesciences products portfolio in cardiac
6.8.3.Strategic moves
6.8.4.SCOT Analysis
6.9.Toshiba Medical Systems
6.9.1.Overview
6.9.2.Toshiba Medical System Products Portfolio in Cardiac
6.9.3.SCOT Analysis
6.10.Lombard Medical
6.10.1.Overview
6.10.2.Lombard Medical products portfolio in cardiac
6.10.3.SCOT Analysis
6.11.Atricure Inc
6.11.1.Overview
6.11.2.Atricure products portfolio in cardiac
6.11.3.SCOT Analysis
6.12.Atrium Medical Corporation
6.12.1.Overview
6.12.2.Atrium Medical products portfolio in cardiac
6.12.3.SCOT Analysis
6.13.Hansen Medical
6.13.1.Overview
6.13.2.Hansen medical Product Portfolio
6.13.3.SCOT Analysis
6.14.GE Healthcare
6.14.1.Overview
6.14.2.GE Healthcare Product Portfolio
6.14.3.Strategic Moves
6.14.4.SCOT Analysis
6.15.Philips Healthcare
6.15.1.Overview
6.15.2.Phillips Healthcare Products Portfolio in Cardiac
6.15.3.Strategic Moves (2013-14)
6.15.4.SCOT Analysis
6.16.Smith Medical
6.16.1.Overview:134
6.16.2.Smiths Medical Products Portfolio in Cardiac
6.16.3.SCOT Analysis
6.17.Berlin Heart
6.17.1.Overview
6.17.2.Berlin heart product portfolio in Cardiac
6.17.3.Strategic Moves (2013-2014)
6.17.4.SCOT Analysis
6.18.Cambridge Heart, Inc.
6.18.1.Overview
6.18.2.Cambridge heart product portfolio in Cardiac
6.18.3.SCOT Analysis
6.19.Johnson & Johnson
6.19.1.Overview
6.19.2.SCOT Analysis
CHAP 2.MARKET OVERVIEW
2.1.Market Estimation Methodology
2.2.Value Chain analysis
2.2.1.Suppliers
2.2.2.Manufacturers
2.2.3.Distributors & Retailers
2.2.4.End Users
2.3.Key Buying Criteria
2.3.1.Quality
2.3.2.Price
2.3.3.Availability
2.3.4.Success rate
2.4.Key Strategies
2.4.1.Innovation Is The Key Industry Strategy to Overcome Competition
2.5.Partnerships, acquisitions and mergers
2.6.Product Launch- a make or break marketing strategy
CHAP 3.MARKET DETERMINANTS
3.1.Drivers
3.1.1.Global increase in life style oriented diseases & fatalities
3.1.2.Medical Tourism
3.1.3.Medical Tourism Organizations
3.1.4.Global increase in healthcare spending
3.1.5.Increasing awareness of healthy lifestyle to drive the market
3.2.Restraints
3.2.1.High Cost of Surgeries
3.2.2.Stringent government policies affect Cardiology market growth
3.3.Opportunities
3.3.1.Research and development to explore healthcare robotics
3.3.2.Technological advancements in surgeries
3.3.3.US FDA approved medical devices
3.4.Challenges
3.4.1.High cost and Adoption issues of medical devices for hospitals and clinics
3.4.2.Reliability Issues
CHAP 4.MARKET SEGMENTATION
4.1.Cardiac rhythm management
4.1.1.Cardiac rhythm management devices
4.1.2.ICD: Cardioverter/defibrillators (ICD's)
4.1.3.Atrial Fibrillation
4.1.3.1.Treatment Options for Atrial Fibrillation
4.1.3.2.Cox-Maze Open Heart Procedure
4.1.3.3.Catheter-based Cardiac Ablation Procedure
4.2.Surgery
4.2.1.Coronary arteries bypass grafting (CABG)
4.2.2.Angioplasty
4.2.3.Transmyocardial Laser Revascularization (TMR)
4.2.4.Heart valve Repair/Replacement
4.2.5.Arrhythmia Treatment
4.2.6.Aneurysm Repair
4.2.7.Heart Transplant
4.2.7.1.Surgery to Place Ventricular Assist Devices or Total Artificial Hearts
4.2.8.Open Heart Surgery
4.2.9.Types of open heart surgery
4.2.10.Off Pump Heart surgery
4.2.11.Minimally invasive surgeries
4.3.Imaging Devices
4.3.1.Still Imaging
4.3.2.Real time imaging
4.3.3.Magnetic Resonance Angiogram (MRA)
4.3.4.Fluoroscopy
4.3.5.Echocardiography
4.4.Cardiac Catheterization
CHAP 5.GEOGRAPHICAL ANALYSIS
5.1.North America
5.1.1.United States (U.S.)
5.1.1.1.US FDA is vigilant over interventional cardiology device market
5.1.2.Canada
5.1.2.1.CVD and other heart diseases are the leading cause of mortality in Canada
5.1.2.2.Regulations in Canada
5.2.Europe
5.2.1.United Kingdom (UK)
5.2.2.France
5.2.3.Germany
5.2.4.Italy
5.2.5.Spain
5.3.Asia Pacific
5.3.1.India
5.3.2.China
5.3.2.1.Diseases prevalent in China
5.3.3.Japan
5.3.4.Korea
5.3.5.Taiwan
5.4.Rest of the World
5.4.1.Brazil
5.4.2.Mexico
5.4.3.South Africa
CHAP 6.CORPORATE PROFILE
6.1.Boston Scientific Corporation
6.1.1.Overview
6.1.2.Boston Scientific Corporation products portfolio in Cardiac
6.1.3.SCOT Analysis
6.2.C.R. Bard
6.2.1.Overview
6.2.2.Bard product portfolio in Cardiac
6.2.3.SCOT Analysis
6.3.Medtronic
6.3.1.Overview
6.3.2.Medtronic product portfolio in Cardiac
6.3.3.Strategic Moves
6.3.4.SCOT Analysis
6.4.Abbot Laboratories
6.4.1.Overview
6.4.2.Abbott laboratories portfolio in cardiac
6.4.3.SCOT Analysis
6.5.St. Jude Medical
6.5.1.Overview
6.5.2.St. Jude medical products portfolio in cardiac
6.5.3.SCOT Analysis
6.6.Cook Medical
6.6.1.Overview
6.6.2.Cook Medical products portfolio in cardiac:
6.6.3.Strategic moves
6.6.4.SCOT Analysis
6.7.Biosense Webster
6.7.1.Overview
6.7.2.Biosense Webster products portfolio in cardiac
6.7.3.SCOT Analysis
6.8.Edwards Lifescience
6.8.1.Overview
6.8.2.Edwards Lifesciences products portfolio in cardiac
6.8.3.Strategic moves
6.8.4.SCOT Analysis
6.9.Toshiba Medical Systems
6.9.1.Overview
6.9.2.Toshiba Medical System Products Portfolio in Cardiac
6.9.3.SCOT Analysis
6.10.Lombard Medical
6.10.1.Overview
6.10.2.Lombard Medical products portfolio in cardiac
6.10.3.SCOT Analysis
6.11.Atricure Inc
6.11.1.Overview
6.11.2.Atricure products portfolio in cardiac
6.11.3.SCOT Analysis
6.12.Atrium Medical Corporation
6.12.1.Overview
6.12.2.Atrium Medical products portfolio in cardiac
6.12.3.SCOT Analysis
6.13.Hansen Medical
6.13.1.Overview
6.13.2.Hansen medical Product Portfolio
6.13.3.SCOT Analysis
6.14.GE Healthcare
6.14.1.Overview
6.14.2.GE Healthcare Product Portfolio
6.14.3.Strategic Moves
6.14.4.SCOT Analysis
6.15.Philips Healthcare
6.15.1.Overview
6.15.2.Phillips Healthcare Products Portfolio in Cardiac
6.15.3.Strategic Moves (2013-14)
6.15.4.SCOT Analysis
6.16.Smith Medical
6.16.1.Overview:134
6.16.2.Smiths Medical Products Portfolio in Cardiac
6.16.3.SCOT Analysis
6.17.Berlin Heart
6.17.1.Overview
6.17.2.Berlin heart product portfolio in Cardiac
6.17.3.Strategic Moves (2013-2014)
6.17.4.SCOT Analysis
6.18.Cambridge Heart, Inc.
6.18.1.Overview
6.18.2.Cambridge heart product portfolio in Cardiac
6.18.3.SCOT Analysis
6.19.Johnson & Johnson
6.19.1.Overview
6.19.2.SCOT Analysis
LIST OF TABLES
TABLE 1 GLOBAL CARDIOLOGY SURGICAL DEVICES MARKET BY SEGMENTS 2014-2022 ($ MILLION)
TABLE 2 FACT SHEET OF CVD FATALITIES
TABLE 3 PRICE DIFFERENCE IN INDIA AND US FOR CARDIAC RELATED SURGERIES
TABLE 6 USFDA APPROVALS IN 2014
TABLE 7 GLOBAL CRDM MARKET BY REGIONS 2014-2022 ($ MILLION)
TABLE 8 GLOBAL CRDM MARKET BY DEVICES 2014-2022 ($ MILLION)
TABLE 9 GLOBAL DEFIBRILLATION SYSTEMS MARKET, BY REGIONS 2014-2022 ($ MILLION)
TABLE 10 GLOBAL ATRIAL FIBRILLATION SYSTEMS MARKET, BY REGIONS 2014-2022 ($ MILLION)
TABLE 11 GLOBAL CORONARY SURGERY MARKET, BY REGIONS 2014-2022 ($ MILLION)
TABLE 12 GLOBAL CARDIAC SURGERY MARKET BY REGIONS 2014-2022 ($ MILLION)
TABLE 13 GLOBAL TRANSMYOCARDIAL LASER REVASCULARIZATION (TMR) MARKET, BY REGIONS, 2013-2021
TABLE 14 GLOBAL HEART VALVE REPLACEMENT MARKET BY REGIONS 2014-2022 ($ MILLION)
TABLE 15 GLOBAL HEART TRANSPLANT SURGERY MARKET, BY REGIONS 2014-2022 ($ MILLION)
TABLE 16 GLOBAL CARDIAC IMAGING MARKET, BY REGIONS, 2013-2021, (IN $ MILLION)
TABLE 17 GLOBAL CARDIAC STENTS MARKET, BY REGIONS 2014-2022 ($ MILLION)
TABLE 18 GLOBAL CARDIAC CATHETERS MARKET, BY REGIONS 2014-2022 ($ MILLION)
TABLE 19 GLOBAL CARDIOLOGY SURGERY MARKET, BY REGIONS 2014-2022 ($ MILLION)
TABLE 20 NORTH AMERICA CARDIOLOGY SURGICAL MARKET, BY REGIONS 2014-2022 ($ MILLION)
TABLE 21 EUROPE CARDIOLOGY SURGICAL MARKET BY REGIONS 2014-2022 ($ MILLION)
TABLE 22 FATALITY IN EUROPE IN 2014
TABLE 23 CVD STATISTICS OF THE UK IN 2014
TABLE 24 NUMBER OF CARDIOLOGISTS IN SPAIN
TABLE 25 ASIA PACIFIC CARDIOLOGY SURGICAL MARKET BY REGIONS 2014-2022 ($ MILLION)
TABLE 27 ROW CARDIOLOGY SURGICAL MARKET BY REGIONS 2014-2022 ($ MILLION)
TABLE 1 GLOBAL CARDIOLOGY SURGICAL DEVICES MARKET BY SEGMENTS 2014-2022 ($ MILLION)
TABLE 2 FACT SHEET OF CVD FATALITIES
TABLE 3 PRICE DIFFERENCE IN INDIA AND US FOR CARDIAC RELATED SURGERIES
TABLE 6 USFDA APPROVALS IN 2014
TABLE 7 GLOBAL CRDM MARKET BY REGIONS 2014-2022 ($ MILLION)
TABLE 8 GLOBAL CRDM MARKET BY DEVICES 2014-2022 ($ MILLION)
TABLE 9 GLOBAL DEFIBRILLATION SYSTEMS MARKET, BY REGIONS 2014-2022 ($ MILLION)
TABLE 10 GLOBAL ATRIAL FIBRILLATION SYSTEMS MARKET, BY REGIONS 2014-2022 ($ MILLION)
TABLE 11 GLOBAL CORONARY SURGERY MARKET, BY REGIONS 2014-2022 ($ MILLION)
TABLE 12 GLOBAL CARDIAC SURGERY MARKET BY REGIONS 2014-2022 ($ MILLION)
TABLE 13 GLOBAL TRANSMYOCARDIAL LASER REVASCULARIZATION (TMR) MARKET, BY REGIONS, 2013-2021
TABLE 14 GLOBAL HEART VALVE REPLACEMENT MARKET BY REGIONS 2014-2022 ($ MILLION)
TABLE 15 GLOBAL HEART TRANSPLANT SURGERY MARKET, BY REGIONS 2014-2022 ($ MILLION)
TABLE 16 GLOBAL CARDIAC IMAGING MARKET, BY REGIONS, 2013-2021, (IN $ MILLION)
TABLE 17 GLOBAL CARDIAC STENTS MARKET, BY REGIONS 2014-2022 ($ MILLION)
TABLE 18 GLOBAL CARDIAC CATHETERS MARKET, BY REGIONS 2014-2022 ($ MILLION)
TABLE 19 GLOBAL CARDIOLOGY SURGERY MARKET, BY REGIONS 2014-2022 ($ MILLION)
TABLE 20 NORTH AMERICA CARDIOLOGY SURGICAL MARKET, BY REGIONS 2014-2022 ($ MILLION)
TABLE 21 EUROPE CARDIOLOGY SURGICAL MARKET BY REGIONS 2014-2022 ($ MILLION)
TABLE 22 FATALITY IN EUROPE IN 2014
TABLE 23 CVD STATISTICS OF THE UK IN 2014
TABLE 24 NUMBER OF CARDIOLOGISTS IN SPAIN
TABLE 25 ASIA PACIFIC CARDIOLOGY SURGICAL MARKET BY REGIONS 2014-2022 ($ MILLION)
TABLE 27 ROW CARDIOLOGY SURGICAL MARKET BY REGIONS 2014-2022 ($ MILLION)
LIST OF FIGURES
FIGURE 6 UNITED STATES CARDIOLOGY SURGICAL MARKET 2014-2022 ($ MILLION)
FIGURE 7 CVD PREVALENCE IN CANADA,2013
FIGURE 8 CANADA CARDIOLOGY SURGICAL MARKET 2014-2022 ($ MILLION)
FIGURE 9 MEN VS WOMEN FATALITY RATES IN EUROPE 2014
FIGURE 10 UNITED KINGDOM CARDIOLOGY SURGICAL MARKET 2014-2022 ($ MILLION)
FIGURE 11 FRANCE CARDIOLOGY SURGICAL MARKET 2014-2022 ($ MILLION)
FIGURE 12 GERMANY CARDIOLOGY SURGICAL MARKET 2014-2022 ($ MILLION)
FIGURE 13 ITALY CARDIOLOGY SURGERY MARKET 2014-2022 ($ MILLION)
FIGURE 14 INDIA CARDIOLOGY SURGICAL MARKET 2014-2022 ($ MILLION)
FIGURE 15 CHINA CARDIOLOGY SURGICAL MARKET 2014-2022 ($ MILLION)
FIGURE 16 JAPAN CARDIOLOGY SURGICAL MARKET 2014-2022 ($ MILLION)
FIGURE 17 SOUTH KOREA CARDIOLOGY SURGICAL MARKET 2014-2022 ($ MILLION)
COMPANIES MENTIONED
1. Boston Scientific Corporation
2. CR Bard
3. Medtronic
4. Abbot Laboratories
5. St Jude Medical
6. Cook Medical
7. Biosense Webster
8. Edwards Lifescience
9. Toshiba Medical Systems
10. Lombard Medical
11. Atricure Inc
12. Atrium Medical Corporation
13. Hansen Medical
14. GE Healthcare
15. Philips Healthcare
16. Smith Medical
17. Berlin Heart
18. Cambridge Heart, Inc
19. Johnson & Johnson
FIGURE 6 UNITED STATES CARDIOLOGY SURGICAL MARKET 2014-2022 ($ MILLION)
FIGURE 7 CVD PREVALENCE IN CANADA,2013
FIGURE 8 CANADA CARDIOLOGY SURGICAL MARKET 2014-2022 ($ MILLION)
FIGURE 9 MEN VS WOMEN FATALITY RATES IN EUROPE 2014
FIGURE 10 UNITED KINGDOM CARDIOLOGY SURGICAL MARKET 2014-2022 ($ MILLION)
FIGURE 11 FRANCE CARDIOLOGY SURGICAL MARKET 2014-2022 ($ MILLION)
FIGURE 12 GERMANY CARDIOLOGY SURGICAL MARKET 2014-2022 ($ MILLION)
FIGURE 13 ITALY CARDIOLOGY SURGERY MARKET 2014-2022 ($ MILLION)
FIGURE 14 INDIA CARDIOLOGY SURGICAL MARKET 2014-2022 ($ MILLION)
FIGURE 15 CHINA CARDIOLOGY SURGICAL MARKET 2014-2022 ($ MILLION)
FIGURE 16 JAPAN CARDIOLOGY SURGICAL MARKET 2014-2022 ($ MILLION)
FIGURE 17 SOUTH KOREA CARDIOLOGY SURGICAL MARKET 2014-2022 ($ MILLION)
COMPANIES MENTIONED
1. Boston Scientific Corporation
2. CR Bard
3. Medtronic
4. Abbot Laboratories
5. St Jude Medical
6. Cook Medical
7. Biosense Webster
8. Edwards Lifescience
9. Toshiba Medical Systems
10. Lombard Medical
11. Atricure Inc
12. Atrium Medical Corporation
13. Hansen Medical
14. GE Healthcare
15. Philips Healthcare
16. Smith Medical
17. Berlin Heart
18. Cambridge Heart, Inc
19. Johnson & Johnson
